These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38073291)

  • 1. The lesion site in malignant psoas syndrome influences the cancer pain intensity.
    Ishii K; Komatsu Y; Mori K; Nagaishi E; Matsuo K; Hashizume J; Ryu E; Ashizawa K; Hara T
    Ann Palliat Med; 2024 Jan; 13(1):57-61. PubMed ID: 38073291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Presentation and Management of Malignant Psoas Syndrome: A Scoping Review of Case Reports and Case Series.
    Suraj D; Zhang A; Appelbaum T; Ahmed N; Shih S; Gofman J; Kalenja K; Abrigo JN; Shaporova V; Mannan A; Jacobs RJ
    Cureus; 2023 Jul; 15(7):e41522. PubMed ID: 37551242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Control of Pain from Malignant Psoas Syndrome by Spinal Opioid with Local Anesthetic Agents.
    Yamaguchi T; Katayama K; Matsumoto M; Sato Y; Nakayama N; Hisahara K
    Pain Pract; 2018 Jun; 18(5):641-646. PubMed ID: 28940900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone for Patients with Malignant Psoas Syndrome: Case Series of Three Patients.
    Takase N; Ikegaki J; Nishimura H; Yuasa S; Ito Y; Kizawa Y
    J Palliat Med; 2015 Jul; 18(7):645-52. PubMed ID: 25961749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analgesic effect of rescue administration of intravenous acetaminophen in cancer patients may be associated with sex and opioid dose, and the effect would appear to patients administered under 45 mg/day opioid (oral morphine equivalents).
    Niki K; Okamoto Y; Nakajima S; Uejima E
    Pharmazie; 2018 Mar; 73(3):161-164. PubMed ID: 29544564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant Hip Flexion Failure Syndrome: An Oncologic Disease Compared to Malignant Psoas Syndrome.
    Ishikawa Y; Teramura S; Ito K; Yamada T
    Cureus; 2024 Aug; 16(8):e67343. PubMed ID: 39170647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements?
    Shinde S; Gordon P; Sharma P; Gross J; Davis MP
    Support Care Cancer; 2015 Mar; 23(3):695-703. PubMed ID: 25168780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The terminal cancer patient: effects of age, gender, and primary tumor site on opioid dose.
    Hall S; Gallagher RM; Gracely E; Knowlton C; Wescules D
    Pain Med; 2003 Jun; 4(2):125-34. PubMed ID: 12873262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain.
    Mercadante S; Porzio G; Adile C; Aielli F; Cortegiani A; Dickenson A; Casuccio A
    Curr Med Res Opin; 2014 Oct; 30(10):2063-8. PubMed ID: 24926734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary psoas sarcoma causing malignant psoas syndrome: favourable response to radiotherapy.
    McKay TA; Bishop S; McKay MJ
    Ann Transl Med; 2017 Mar; 5(5):105. PubMed ID: 28361070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit.
    Peirano GP; Mammana GP; Bertolino MS; Pastrana T; Vega GF; Russo J; Varela G; Vignaroli E; Ruggiero R; Armesto A; Camerano G; Dran G
    Support Care Cancer; 2016 Aug; 24(8):3551-6. PubMed ID: 27022964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose and Duration of Opioid Use in Patients with Cancer and Noncancer Pain at an Outpatient Hospital Setting in Malaysia.
    Zin CS; Rahman NA; Ismail CR; Choy LW
    Pain Pract; 2017 Jul; 17(6):774-781. PubMed ID: 27676695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
    Mercadante S; Ferrera P; Adile C; Casuccio A
    J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Unusual Case of Hip Flexion Failure Caused by Bone Metastasis From Hepatocellular Carcinoma Infiltrating the Psoas Muscle.
    Ishikawa Y; Teramura S; Ito K; Yamada T
    Cureus; 2023 Dec; 15(12):e49996. PubMed ID: 38077682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses.
    Mercadante S; Gatti A; Porzio G; Lo Presti C; Aielli F; Adile C; Casuccio A
    Curr Med Res Opin; 2012 Jun; 28(6):963-8. PubMed ID: 22480130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
    Kiehelä L; Hamunen K; Heiskanen T
    Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain.
    Palangio M; Northfelt DW; Portenoy RK; Brookoff D; Doyle RT; Dornseif BE; Damask MC
    J Pain Symptom Manage; 2002 May; 23(5):355-68. PubMed ID: 12007754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Emergency Department Management of Opioid-Tolerant Cancer Patients With Acute Pain.
    Patel PM; Goodman LF; Knepel SA; Miller CC; Azimi A; Phillips G; Gustin JL; Hartman A
    J Pain Symptom Manage; 2017 Oct; 54(4):501-507. PubMed ID: 28729010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-free analgesia by continuous psoas compartment block after total hip arthroplasty. A randomized study.
    Becchi C; Al Malyan M; Coppini R; Campolo M; Magherini M; Boncinelli S
    Eur J Anaesthesiol; 2008 May; 25(5):418-23. PubMed ID: 18028577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.